| Name | Traded | Action | Notifier | Last | Amount | Value |
|---|---|---|---|---|---|---|
| AstraZeneca | 19-Nov-24 | Buy | Tony Mok | 12,679.63p | 1,500 | £190,194.50 |
| 4basebio | 15-Nov-24 | Sell | Heikki Lanckriet | 1,325.00p | 46,500 | £616,125.00 |
| AstraZeneca | 15-Nov-24 | Buy | Michel Demare | 10,030.35p | 2,000 | £200,607.04 |
| 4basebio | 15-Nov-24 | Buy | Heikki Lanckriet | 1,325.00p | 46,500 | £616,125.00 |
| GSK | 15-Nov-24 | Buy | Hal Barron | $33.35 | 3,447 | $94,797.19 |
| Name | Traded | Action | Notifier | Last | Amount | Value |
|---|---|---|---|---|---|---|
| GSK | 16-Apr-24 | Buy Dividends | Hal Barron | $39.79 | 2,906,213 | $95,366,062.48 |
| GSK | 16-Apr-24 | Buy Dividends | Emma Walmsley | 1,611.28p | 1,840,922 | £29,662,409.10 |
| Destiny Pharma | 02-Aug-24 | Buy | Nigel Rudd | 250.00p | 1,240,000 | £3,100,000.00 |
| Oxford Nanopore Technologies | 15-Oct-24 | Sell | Gurdial (Gordon) Sanghera | 141.66p | 1,993,571 | £2,824,112.62 |
| Bioventix | 29-Jan-24 | Sell | Peter John Harrison | 4,200.00p | 62,000 | £2,604,000.00 |